Polymorphic variation in surfactant protein B is associated with COPD exacerbations. - Wikidata - wikimedia - TriplyDB

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

http://www.wikidata.org/entity/Q37387050

about

Updates on the COPD gene list Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation Chronic obstructive pulmonary disease: towards pharmacogenetics.Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease.Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods.Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)COPD: it is time to change!Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation.CT metrics of airway disease and emphysema in severe COPD.Gender Differences in Pulmonary Function, Respiratory Symptoms, and Macrophage Proteomics among HIV-Infected Smokers.Pulmonary surfactant: an immunological perspective.The recent advances of phenotypes in acute exacerbations of COPD.Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?Lack of association between the TGF-β(1) gene and development of COPD in Asians: a case-control study and meta-analysis.The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema.Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.Immune-related gene polymorphisms in pulmonary diseases.Relationship between the microsatellite D2S388-5 and D2S2232 polymorphisms and chronic obstructive pulmonary disease in the Chinese Kazakh population.Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study.Functional characterization of a porcine emphysema model.Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis

P2860

Q26824935-E549019D-6A44-4DF2-A9C3-DA8C931BDED1 Q27000043-DB7CC08E-45FE-4788-90F8-010C65BBE9A5 Q33541285-D29D0B60-5E0A-4A1B-B84C-871AA00787A9 Q33600138-F1EC3F48-208E-441C-9A96-0BC46413C558 Q33706037-1D5CF3A6-80CC-4948-947E-904A6B27F7D2 Q34535065-12790445-4F32-4D49-BD4D-5DFDE8F28EBB Q34995861-75600198-60CE-4E4E-8CF2-24A51F0F054A Q36060275-BF7890C0-C6DE-47C3-A5B8-188E1BF2825E Q36288971-AD680FFE-BA3E-4A4F-9A2B-686D45055DEF Q37033867-9F0B1819-4469-4549-B1A4-81A928B5EAC5 Q37323723-FB180C76-044C-4399-A1C1-972B999828BB Q37651113-A1FC4815-3EAE-46D4-AD43-A586DA6144E3 Q37669627-37D26C34-559E-42E8-B4C9-9658107F5398 Q37732387-F89E0557-19DC-4FBE-B5D3-E32274D3E68A Q37776725-1A5EE948-F28C-4F3D-B7A6-305B4F2BF4AA Q37873790-339A0CBC-2B7F-4724-8074-F8C1664F79CC Q37901242-EBCF9CB3-C78B-42F2-BCA5-674B1DE3C072 Q38729391-F347F678-0189-46E3-8507-0F2CD104F47A Q39214085-E44F42B2-2277-4159-A1E6-5A823B27A17A Q44036917-03E9D444-9EFA-4F04-AD76-0AB66CDA6434 Q44279162-57FA77BF-E584-4D32-969F-388310FB32B7 Q45894876-5DB38FDE-8D5D-4EF2-BA18-F51A29E38A38 Q58586433-5916F689-D63B-4A00-9A4F-06648670E269

P2860

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

http://www.wikidata.org/entity/Q37387050

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@en

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@nl

type

label

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@en

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@nl

prefLabel

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@en

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

@nl

P1433

Q37387050-1E53A773-BB87-4B75-B35D-1C436CE036D5

P1476

Q37387050-E6C3C3DD-EF1F-4BBA-BE88-7A4DCA71308D

P2093

Q37387050-04789E5F-AAED-4E25-A959-734849048BD4

Q37387050-599A2A08-9CBB-48D7-9B05-47F112C7A7CC

Q37387050-9A5DE29C-DA7F-4205-9719-179EBB398EFC

Q37387050-A51A007D-3B20-402A-BC2D-CA9BD570B02C

Q37387050-B69E38FD-86E1-48AB-80B3-3902EC6371EB

Q37387050-E2210B0E-31A1-4006-9AE3-D0FD04EFFE0A

Q37387050-E83D0E76-F221-4426-9795-300378C9AA14

P2860

Q37387050-00E04B60-C796-4DCE-8B12-6C98AB7D1BE9

Q37387050-017134CC-342C-4CF5-893B-E0617DA151C0

Q37387050-08AE8C21-4D2E-45B2-B6CA-8D588B5629BE

Q37387050-0CFCBE5D-CA16-4FAE-B258-7870728F7A07

Q37387050-0D0E2EA5-73B9-492B-B9AF-8EFF5017D8C6

Q37387050-16884AEA-E06C-4CF7-BFD1-28549F9E36AC

Q37387050-1C0D5475-16FE-45EE-B55D-DB6EC5E90EEA

Q37387050-1DD1B1F5-5C7B-45FB-A2FB-66B5AD407823

Q37387050-2DAB577D-7754-425E-A12D-80813D0C0CEF

Q37387050-3347E9D2-BBB0-4ABF-A9F9-A27ACD1766D8

P304

Q37387050-08CDFBB8-FD81-44F2-89DB-C1B8B1113E1B

P31

Q37387050-DAE05074-5557-47BC-AA56-0041B7D657BC

P356

Q37387050-FE9582CC-064E-45CD-912F-6AFC59345A9C

P433

Q37387050-450ED45B-1EC8-43FC-BBE8-318078771F5D

P478

Q37387050-7D3AC2A6-6851-4851-9C8A-6941B336E5B7

P50

Q37387050-4654BB9E-255C-4EEB-B348-6683845079D0

P577

Q37387050-2AB6E17E-AAE6-4F8A-83B8-67EE963411CC

P5875

Q37387050-0CE987BB-FDBD-486C-AFC8-60E67638B052

P698

Q37387050-35A5DB3B-0DB5-4D11-ABD3-F010D3193DCE

P932

Q37387050-D662F271-8803-406C-AC4C-487B205AECD5

P356

09031936.00040208

P1433

European Respiratory Journal

P1476

Polymorphic variation in surfactant protein B is associated with COPD exacerbations

@en

P2093

C P Hersh

http://www.w3.org/2001/XMLSchema#string

D L DeMeo

http://www.w3.org/2001/XMLSchema#string

E K Silverman

http://www.w3.org/2001/XMLSchema#string

J J Reilly

http://www.w3.org/2001/XMLSchema#string

S D Shapiro

http://www.w3.org/2001/XMLSchema#string

V J Carey

http://www.w3.org/2001/XMLSchema#string

V S Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

A haplotype map of the human genome

Haploview: analysis and visualization of LD and haplotype maps

Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

Score tests for association between traits and haplotypes when linkage phase is ambiguous

Pulmonary surfactant in health and human lung diseases: state of the art.

Pharmacoeconomic evaluation of COPD.

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Hydrophobic surfactant proteins in lung function and disease.

P304

938-944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00040208

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Marilyn G. Foreman

P577

2008-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5305643

http://www.w3.org/2001/XMLSchema#string

P698

18550614

http://www.w3.org/2001/XMLSchema#string

P932

2761762

http://www.w3.org/2001/XMLSchema#string